CD4+ T cells specific of the InsB30-C13 peptide (hPPI55-69) have been reported in 68% of HLA-DQ2/DQ8-restricted T1D patients versus 37% in healthy donors (59). This evidence concerns the gene CD4 and type 1 diabetes mellitus.